Is Rocket Lab a Buy, Sell, or Hold After Its 85th Mission?

Rocket Lab completed its 85th mission, signaling continued operational execution. Options activity has surged and investor expectations are elevated, introducing valuation and volatility risk despite strong execution. Stock prices referenced were as of April 3, 2026 and the video/commentary published April 7, 2026. Disclosure: The Motley Fool holds and recommends Rocket Lab, which may influence the bullish framing.

Analysis

Rocket Lab’s cadence advantage is a real optionality lever: sustained high-frequency launches can push learning-curve unit costs down by an estimated 10–20% per doubling of cumulative launches, which meaningfully widens gross-margin runway for both launch and in-house spacecraft/parts lines. That same cadence, however, forces heavier front-loaded capex and creates a timing mismatch: cash conversion from Neutron-scale investments will lag any unit-cost benefits by multiple quarters to years, making near-term profitability highly sensitive to manifest fill rates.

Elevated options activity has two second-order effects on price dynamics: concentrated retail/market-maker gamma around popular strikes amplifies intraday moves and increases the chance of outsized gaps on both positive mission surprises and operational setbacks. For traders this structurally raises the skew premium, so selling short-dated premium looks attractive but carries asymmetric tail risk — a single failure or regulatory delay can wipe out weeks of theta collected.

Key reversal triggers are operational (engine/ground-failure, supplier bottlenecks in turbopumps/composite structures), regulatory (FAA/ITAR/FCC pacing), and macro (satellite capex cycles); any one can turn the growth narrative into a multi-quarter re-pricing event. Over a 3–12 month horizon, the clearest path to derating is manifest cancellations or material Neutron timeline slippage; conversely, multi-quarter manifest expansion or repeated flawless flights compresses perceived execution risk and could re-rate multiples sharply upward.

Key Decisions for Investors

• Core long + hedge (RKLB): Buy a base equity position size = 1–2% NAV; simultaneously buy 3-month 15% OTM puts to cap downside (~2–3% premium target). R/R: limited defined loss vs open upside to multi-quarter re-rating; ideal for investors who want exposure without single-mission tail risk.
• Income overlay (RKLB): Sell 30–60 day covered calls ~15–20% OTM against up to 50% of the position to harvest elevated IV while retaining upside exposure. R/R: collects premium (~high single-digit annualized against position) but caps upside between strikes; rotate covered-call proceeds into defensive tech (AAPL) on strong rallies.
• Tactical short-vol after launch windows (RKLB): If implied vol compresses immediately post-mission, sell 7–14 day strangles with strict notional caps and dynamic delta-hedging; set a max loss stop at 2–3x premium collected. R/R: high theta capture in calm post-event weeks, but severe tail if gap occurs — use only small size (0.5–1% NAV).
• Rebalance vs narrative longs (NFLX/AAPL): If RKLB runs >30% on multiple flawless missions, take profits and redeploy into higher-quality, lower-volatility tech (AAPL) or realize gains from NFLX long exposure to rebalance portfolio volatility. R/R: locks realized alpha from execution story while lowering portfolio tail-risk exposure.